
Kashif Saleem
Articles
-
2 months ago |
bravenewcoin.com | Ahmed Ishtiaque |Aditya Das |Kashif Saleem
Pepe Coin (PEPE) has experienced a significant price surge, rising by 11.27% in the past 24 hours to reach $0.000006370. This rebound comes after a prolonged bearish trend that saw the meme coin plummet over 80% from its all-time high of $0.00002833 in December 2024. Following this surge, analysts are becoming more optimistic, predicting that PEPE could break the $0.000010 barrier if bullish momentum continues.
-
2 months ago |
bravenewcoin.com | Aditya Das |Ahmed Ishtiaque |Kashif Saleem |David McNickel
The Trump Tariffs – 4D Chess or Disaster For Global Markets? Trade wars usually send ripples through financial markets, but the announcements of the Trump Tariffs have created more than just a ripple, with a storm of downside volatility crashing both Bitcoin and the stock market. It is likely not the direct effect of Tariffs that are crashing markets but the wider impact they may yet have on the US and global economy.
-
2 months ago |
translational-medicine.biomedcentral.com | Laith Mohammad Abualigah |Kashif Saleem |Vaclav Snasel |Hazem Migdady |Raed Abu Zitar |Aseel Smerat | +3 more
Advancements in artificial intelligence (AI) and machine learning (ML) have revolutionized the medical field and transformed translational medicine. These technologies enable more accurate disease trajectory models while enhancing patient-centered care. However, challenges such as heterogeneous datasets, class imbalance, and scalability remain barriers to achieving optimal predictive performance. This study proposes a novel AI-based framework that integrates Gradient Boosting Machines (GBM) and Deep Neural Networks (DNN) to address these challenges. The framework was evaluated using two distinct datasets: MIMIC-IV, a critical care database containing clinical data of critically ill patients, and the UK Biobank, which comprises genetic, clinical, and lifestyle data from 500,000 participants. Key performance metrics, including Accuracy, Precision, Recall, F1-Score, and AUROC, were used to assess the framework against traditional and advanced ML models. The proposed framework demonstrated superior performance compared to classical models such as Logistic Regression, Random Forest, Support Vector Machines (SVM), and Neural Networks. For example, on the UK Biobank dataset, the model achieved an AUROC of 0.96, significantly outperforming Neural Networks (0.92). The framework was also efficient, requiring only 32.4 s for training on MIMIC-IV, with low prediction latency, making it suitable for real-time applications. The proposed AI-based framework effectively addresses critical challenges in translational medicine, offering superior predictive accuracy and efficiency. Its robust performance across diverse datasets highlights its potential for integration into real-time clinical decision support systems, facilitating personalized medicine and improving patient outcomes. Future research will focus on enhancing scalability and interpretability for broader clinical applications.
-
Feb 12, 2025 |
bravenewcoin.com | Kashif Saleem |Naveed Iqbal
90% of Russia-India Trade Now in National Currencies — What’s Next for BRICS De-Dollarization? Russia and India have deepened financial ties, significantly cutting reliance on the U.S. dollar. Nearly 90% of direct transactions between the two nations are now conducted in rubles and rupees. This move, part of a broader trend of de-dollarization, marks a milestone in economic cooperation between Moscow and New Delhi.
-
Feb 12, 2025 |
bravenewcoin.com | Kashif Saleem |Naveed Iqbal |Kelvin Maina
50% of Global Assets Now Held by Non-Banks, Warns BoE ChiefSpeaking at The University of Chicago Booth School of Business in London, Andrew Bailey, the Bank of England’s Governor, raised concerns over the influence of non-bank financial (NBFIs) institutions in global markets. Andrew Bailey raised concerns over the growing influence of non-bank financial (NBFIs) institutions in global markets.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →